These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3442620)

  • 1. [Immune complexes as markers in breast cancer and melanoma].
    Cappellari A; Corradi G
    Boll Ist Sieroter Milan; 1987; 66(4):303-7. PubMed ID: 3442620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune complexes in neoplastic diseases and autoimmune processes].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG; Vygovskaia IaI; Zakharchuk LS
    Vopr Onkol; 1983; 29(8):3-7. PubMed ID: 6613066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune complex study of malignant neoplasm patients].
    Bilynskiĭ BT; Fetsich TG
    Vrach Delo; 1983 May; (5):85-7. PubMed ID: 6880177
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
    Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
    Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circulating immune complexes and immunologic reactivity in breast cancer].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
    Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of some tumor markers (secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein, circulating immune complexes in the serum of patients with breast tumors].
    Briese V; Strache RR; Büttner HH; Kunze M; Brock J; Röpcke G
    Zentralbl Gynakol; 1987; 109(5):265-73. PubMed ID: 3591061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in patients with melanoma.
    Sztaba-Kania M; Jassem J; Piskorzyńska M; Kondrat W
    Neoplasma; 1981; 28(4):491-6. PubMed ID: 7027060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complex-like materials in sera of patients with breast cancer: detection by complement-consumption assay.
    Sulitzeanu D; Asaf O; Biran S; Brufman G; Gilead Z
    Isr J Med Sci; 1981; 17(9-10):869-73. PubMed ID: 7309475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating and tumor tissue-bound immune complexes in patients with breast cancer].
    Dorosevich AE
    Arkh Patol; 1983; 45(7):30-6. PubMed ID: 6354144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-complexes in malignant skin melanoma: quantitation by three methods, purification, and characterization of their non-tumor related constituents.
    Borzini P; Del Giudice G; Natali S; Serino G; Nembri P; Manca F; Zanussi C
    Boll Ist Sieroter Milan; 1980 Sep; 59(4):366-73. PubMed ID: 7470278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
    Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
    Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
    Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.
    Vlock DR; Kirkwood JM
    J Clin Invest; 1985 Aug; 76(2):849-54. PubMed ID: 3875634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferritin levels and circulating immune complexes in patients with solid tumors.
    Celada A; Barnet M; Aguado MT; Cruchaud A; Lambert PH
    Bull Cancer; 1982; 69(1):22-7. PubMed ID: 6978747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
    Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural humoral immunity in patients with malignant disease.
    Higuchi M; Gupta RK; Irie RF; Morton DL
    J Clin Lab Immunol; 1980 Nov; 4(3):141-3. PubMed ID: 7193740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccine.
    Wascher RA; Morton DL; Kuo C; Elashoff RM; Wang HJ; Gerami M; Hoon DS
    J Clin Oncol; 2003 Jul; 21(13):2558-63. PubMed ID: 12829676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.